Deferred Systemic Therapy (DST) for Metastatic Renal Cell Carcinoma: Preliminary Prospective Experience
Deferred Systemic Therapy (DST) for Metastatic Renal Cell Carcinoma: Preliminary Prospective...
Read More
Kidney Cancer Journal
DART Study: A phase 2 randomized trial of dalantercept plus axitinib versus placebo plus axitinib in advanced renal cell carcinoma (RCC): Results from the part 2 placebo controlled trial.
DART Study: A phase 2 randomized trial of dalantercept plus axitinib versus placebo plus axitinib...
Read More
Comparative Genomic Profiling of Matched Primary and Metastatic Tumors in Renal Cell Carcinoma
Clinicopathological characterization and oncologic outcomes of metastatic small renal masses...
Read More
Clinical outcomes of patients treated with local therapies with oligometastatic renal cell carcinoma (mRCC).
Clinical outcomes of patients treated with local therapies with oligometastatic renal cell...
Read More
Clinical outcome of patients with metastatic Renal Cell Carcinoma (mRCC) progressing on front-line combination regimens that include checkpoint inhibitors
Clinical outcome of patients with metastatic Renal Cell Carcinoma (mRCC) progressing on front-line...
Read More